Mice Lacking NMDA Receptors in Parvalbumin Neurons Display Normal Depression-Related Behavior and Response to Antidepressant Action of NMDAR Antagonists
出版年份 2014 全文链接
标题
Mice Lacking NMDA Receptors in Parvalbumin Neurons Display Normal Depression-Related Behavior and Response to Antidepressant Action of NMDAR Antagonists
作者
关键词
-
出版物
PLoS One
Volume 9, Issue 1, Pages e83879
出版商
Public Library of Science (PLoS)
发表日期
2014-01-17
DOI
10.1371/journal.pone.0083879
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Neocortical Somatostatin-Expressing GABAergic Interneurons Disinhibit the Thalamorecipient Layer 4
- (2013) Han Xu et al. NEURON
- GLYX-13, a NMDA Receptor Glycine-Site Functional Partial Agonist, Induces Antidepressant-Like Effects Without Ketamine-Like Side Effects
- (2013) Jeffrey Burgdorf et al. NEUROPSYCHOPHARMACOLOGY
- Rapid and Longer-Term Antidepressant Effects of Repeated Ketamine Infusions in Treatment-Resistant Major Depression
- (2012) James W. Murrough et al. BIOLOGICAL PSYCHIATRY
- Targeting the Glutamatergic System to Treat Major Depressive Disorder
- (2012) Daniel C. Mathews et al. DRUGS
- Fast-spiking interneurons and gamma oscillations may be involved in the antidepressant effects of ketamine
- (2012) Zhi-qiang Zhou et al. MEDICAL HYPOTHESES
- Capturing the Angel in "Angel Dust": Twenty Years of Translational Neuroscience Studies of NMDA Receptor Antagonists in Animals and Humans
- (2012) B. Moghaddam et al. SCHIZOPHRENIA BULLETIN
- Anterior Cingulate Cortexγ-Aminobutyric Acid in Depressed Adolescents
- (2011) Vilma Gabbay ARCHIVES OF GENERAL PSYCHIATRY
- GABA-related transcripts in the dorsolateral prefrontal cortex in mood disorders
- (2011) Etienne Sibille et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- A critical role for NMDA receptors in parvalbumin interneurons for gamma rhythm induction and behavior
- (2011) M Carlén et al. MOLECULAR PSYCHIATRY
- Neocortical excitation/inhibition balance in information processing and social dysfunction
- (2011) Ofer Yizhar et al. NATURE
- NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses
- (2011) Anita E. Autry et al. NATURE
- The GABA system in anxiety and depression and its therapeutic potential
- (2011) Hanns Möhler NEUROPHARMACOLOGY
- Towards a glutamate hypothesis of depression
- (2011) Gerard Sanacora et al. NEUROPHARMACOLOGY
- NMDA Receptor Ablation on Parvalbumin-Positive Interneurons Impairs Hippocampal Synchrony, Spatial Representations, and Working Memory
- (2010) Tatiana Korotkova et al. NEURON
- The rise of a new GABA pharmacology
- (2010) Hanns Möhler NEUROPHARMACOLOGY
- MK-801 produces a deficit in sucrose preference that is reversed by clozapine, d-serine, and the metabotropic glutamate 5 receptor positive allosteric modulator CDPPB: Relevance to negative symptoms associated with schizophrenia?
- (2010) Joshua D. Vardigan et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Evidence of Cortical Inhibitory Deficits in Major Depressive Disorder
- (2009) Andrea J. Levinson et al. BIOLOGICAL PSYCHIATRY
- Targeting Glutamatergic Signaling for the Development of Novel Therapeutics for Mood Disorders
- (2009) Rodrigo Machado-Vieira et al. CURRENT PHARMACEUTICAL DESIGN
- Parvalbumin neurons and gamma rhythms enhance cortical circuit performance
- (2009) Vikaas S. Sohal et al. NATURE
- Driving fast-spiking cells induces gamma rhythm and controls sensory responses
- (2009) Jessica A. Cardin et al. NATURE
- GABA Regulates Excitatory Synapse Formation in the Neocortex via NMDA Receptor Activation
- (2008) D. D. Wang et al. JOURNAL OF NEUROSCIENCE
- Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders
- (2008) Gerard Sanacora et al. NATURE REVIEWS DRUG DISCOVERY
- GABA Neurons and the Mechanisms of Network Oscillations: Implications for Understanding Cortical Dysfunction in Schizophrenia
- (2008) G. Gonzalez-Burgos et al. SCHIZOPHRENIA BULLETIN
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started